GAVI congratulates Dr Mark Dybul on his appointment to lead the Global Fund

in page functions

Statement by GAVI CEO, Seth Berkley MD, following the appointment of Dr Mark Dybul as the new Executive Director of The Global Fund to Fight AIDS, Tuberculosis and Malaria

Dr Mark Dybul

Dr Mark Dybul GFATM2012

"I am delighted to congratulate Mark on his appointment as Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. As a recognised leader in the fight against AIDS, Mark understands the challenges facing the global health community today. I am confident that he will bring new strategies and new energy to the Global Fund."

"Given my background at IAVI I have a personal interest in the development of an AIDS vaccine but of course new vaccines will potentially have an important role to play in tackling tuberculosis and malaria. I will work closely with Mark to ensure that when vaccines against these diseases are available people will have access to them no matter where they live."

"I look forward to working with Mark and his team as we continue our shared mission of improving the health of millions of people across the world."

52 million

Since 2007, countries have immunised 52 million children with a second dose of measles vaccine and 15 million with a first dose of measles-rubella vaccine through Gavi-supported routine immunisation programmes. Gavi-funded campaigns with these two vaccines have helped to vaccinate another 370 million children in countries at high risk of outbreaks.

WHO/UNICEF and Gavi 2018

More facts...

close icon

modal window here